People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellanome, Inc. | — | Biotechnology | Series D+ | $213.7M | $2.0B | 2023 |
| Attralus, Inc. | — | Biotechnology | Series D+ | $172.8M | $709.1M | 2024 |
| Alert Holding Company, Inc. | — | Other | Series B | $48.4M | $270.9M | 2023 |
Mehdi Khodadad at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mehdi Khodadad on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Deven Parekh | 1 | 21 |
| Michael Davis | 1 | 19 |
| JEFF SMITH | 1 | 17 |
| Anika Agarwal | 1 | 13 |
| Corey Goodman | 1 | 13 |
| Brian Moore | 1 | 9 |
| Scott Barclay | 1 | 8 |
| Mostafa Ronaghi | 1 | 8 |
| Rowan Chapman | 1 | 7 |
| Richard Gaster | 1 | 7 |
| James Pade | 1 | 6 |
| Krishnan Sastry | 1 | 5 |
| Behdad Eghbali | 1 | 5 |
| Neal Wolin | 1 | 4 |
| Euan Menzies | 1 | 4 |
| Kazutaka Ohno | 1 | 4 |
| Jay Flatley | 1 | 3 |
| Paul Huber | 1 | 3 |
| Todd Laddusaw | 1 | 3 |
| Darren Moore | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.